Study of FPA008 in Combination With Nivolumab in Patients With Selected Advanced Cancers
Study Number: 

PH 277715

Phase: 
Early Phase
Trial categories: 
Early Phase Clinical Trial
Immunotherapy
Antibody therapy
Checkpoint blockade
Principal Investigator: